Dose impaired relaxation of left ventricle affect early outcomes in CABG patients?

Jamshid Bagheri1, Fereshteh Rezakhanloo

  • 1Department of Cardiovascular Surgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Jbagheri@sina.tums.ac.ir

Acta Medica Iranica
|December 9, 2010
PubMed

Insights

Diastolic dysfunction may impact cardiac surgery outcomes. This study suggests impaired relaxation is a significant factor in predicting complications after coronary artery bypass grafting, even with normal ejection fraction.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Systolic dysfunction is a known prognostic factor in cardiac surgery.
  • The predictive role of diastolic dysfunction, particularly impaired relaxation, is less understood.

Purpose of the Study:

  • To evaluate diastolic dysfunction as a predictive factor for outcomes in patients undergoing isolated coronary artery bypass grafting (CABG).

Main Methods:

  • Retrospective analysis of 872 patients undergoing isolated CABG between January 2008 and February 2009.
  • Patients with normal left ventricular ejection fraction (>50%) were divided into two groups: without diastolic dysfunction (n=361) and with diastolic dysfunction (n=27).
  • Comparison of demographic data, risk factors, complication rates, and mortality between the two groups.

Main Results:

  • The group with diastolic dysfunction showed a higher overall complication rate (11.1% vs. 2.8%, P=0.05).
  • No significant statistical difference was found in individual complication types or mortality rates (7.4% vs. 2.2%, P=0.1) between the groups.
  • Mean age and prevalence of risk factors like diabetes, hypertension, and dyslipidemia were similar between groups.

Conclusions:

  • Diastolic dysfunction, characterized by impaired relaxation, can be a clinically significant factor in assessing surgical outcomes for patients undergoing coronary artery bypass grafting.
  • Further research is warranted to fully elucidate the impact of diastolic dysfunction on cardiac surgery prognosis.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...